RNAC

Cartesian Therapeutics Inc. (ticker: RNAC), based in Watertown, Massachusetts, is a clinical-stage biopharmaceutical leader specializing in nanoparticle immunomodulatory therapeutics designed to enhance immune responses across various therapeutic fields. Utilizing its cutting-edge drug platform, the company is focused on addressing critical unmet medical needs and is advancing a promising pipeline of biotherapeutics currently in clinical evaluation. With its commitment to innovation and patient care, Cartesian Therapeutics is well-positioned to significantly impact the biopharmaceutical landscape, particularly in the realm of immune-mediated therapies.